M1 Kliniken AG (ETR:M12)
Germany · Delayed Price · Currency is EUR 19.00
0.00 (0.00%)
May 29, 2026, 5:35 PM CET
M1 Kliniken AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 364.3 | 339.18 | 316.32 | 285.29 | 314.61 | |
Revenue Growth (YoY) | 7.41% | 7.23% | 10.88% | -9.32% | 97.14% |
Cost of Revenue | 311.38 | 295.76 | 283.85 | 254.06 | 281.89 |
Gross Profit | 52.92 | 43.42 | 32.47 | 31.23 | 32.72 |
Selling, General & Admin | 1.88 | 2.34 | 1.98 | 1.66 | 1.67 |
Other Operating Expenses | 11.97 | 10.17 | 9.82 | 14.57 | 13.23 |
Operating Expenses | 18.73 | 17.67 | 17.11 | 22.29 | 20.59 |
Operating Income | 34.19 | 25.75 | 15.37 | 8.94 | 12.14 |
Interest Expense | -1.54 | -1.93 | -1.35 | -0.83 | -0.92 |
Interest & Investment Income | 1.04 | 0.99 | 2.1 | 1.5 | 1.87 |
Currency Exchange Gain (Loss) | 0.04 | 0.53 | -0.07 | -0.07 | -0.3 |
Other Non Operating Income (Expenses) | 0.18 | 0.37 | 0.01 | 0.26 | 0.04 |
EBT Excluding Unusual Items | 33.91 | 25.71 | 16.06 | 9.81 | 12.84 |
Gain (Loss) on Sale of Investments | - | 0.48 | -0 | 0.22 | 1.33 |
Gain (Loss) on Sale of Assets | 0.13 | 0.07 | 0.24 | 0.01 | 0.01 |
Pretax Income | 34.06 | 26.3 | 16.45 | 10.23 | 14.42 |
Income Tax Expense | 9.96 | 8.51 | 4.78 | 3.16 | 3.54 |
Earnings From Continuing Operations | 24.1 | 17.79 | 11.67 | 7.07 | 10.88 |
Minority Interest in Earnings | -1.97 | -1.77 | -1.39 | -2.75 | -1.97 |
Net Income | 22.13 | 16.02 | 10.27 | 4.32 | 8.91 |
Net Income to Common | 22.13 | 16.02 | 10.27 | 4.32 | 8.91 |
Net Income Growth | 38.17% | 55.91% | 137.98% | -51.52% | 30.52% |
Shares Outstanding (Basic) | 19 | 19 | 19 | 18 | 19 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 18 | 19 |
Shares Change (YoY) | - | -2.98% | 4.43% | -1.43% | -0.02% |
EPS (Basic) | 1.19 | 0.86 | 0.54 | 0.24 | 0.48 |
EPS (Diluted) | 1.19 | 0.86 | 0.54 | 0.24 | 0.48 |
EPS Growth | 38.17% | 60.70% | 127.89% | -50.82% | 30.54% |
Free Cash Flow | 37.84 | 29.78 | 7.35 | 19.61 | 14.66 |
Free Cash Flow Per Share | 2.04 | 1.60 | 0.39 | 1.07 | 0.79 |
Dividend Per Share | 1.200 | 0.500 | 0.500 | - | - |
Dividend Growth | 140.00% | - | - | - | - |
Gross Margin | 14.53% | 12.80% | 10.27% | 10.95% | 10.40% |
Operating Margin | 9.38% | 7.59% | 4.86% | 3.14% | 3.86% |
Profit Margin | 6.08% | 4.72% | 3.25% | 1.51% | 2.83% |
Free Cash Flow Margin | 10.39% | 8.78% | 2.33% | 6.87% | 4.66% |
EBITDA | 35.38 | 27.14 | 16.92 | 10.6 | 14.42 |
EBITDA Margin | 9.71% | 8.00% | 5.35% | 3.71% | 4.58% |
D&A For EBITDA | 1.19 | 1.39 | 1.55 | 1.65 | 2.29 |
EBIT | 34.19 | 25.75 | 15.37 | 8.94 | 12.14 |
EBIT Margin | 9.38% | 7.59% | 4.86% | 3.14% | 3.86% |
Effective Tax Rate | 29.25% | 32.35% | 29.06% | 30.91% | 24.57% |